首页> 美国卫生研究院文献>BMC Complementary and Alternative Medicine >Mutagenicity of Chinese traditional medicine Semen Armeniacae amarum by two modified Ames tests
【2h】

Mutagenicity of Chinese traditional medicine Semen Armeniacae amarum by two modified Ames tests

机译:两种改良的Ames试验对中药Se药的致突变性

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

BackgroundSemen armeniacae amarum (SAA) is a Chinese traditional medicine and has long been used to control acute lower respiratory tract infection and asthma, as a result of its expectorant and antiasthmatic activities. However, its mutagenicity in vitro and in vivo has not yet been reported. The Ames test for mutagenicity is used worldwide. The histidine contained in biological samples can induce histidine-deficient cells to replicate, which results in more his+ colonies than in negative control cells, therefore false-positive results may be obtained. So, it becomes a prerequisite to exclude the effects of any residual histidine from samples when they are assayed for their mutagenicity. Chinese traditional herbs, such as SAA, are histidine-containing biological sample, need modified Ames tests to assay their in vitro mutagenicity.
机译:背景arm仁(Semen armeniacae amarum,SAA)是一种中药,由于其祛痰和平喘作用,长期以来一直用于控制急性下呼吸道感染和哮喘。然而,尚未报道其在体外和体内的致突变性。致突变性的Ames测试已在全球范围内使用。生物样品中包含的组氨酸可以诱导组氨酸缺陷的细胞复制,从而导致比阴性对照细胞更多的his + 克隆,因此可以获得假阳性结果。因此,在测定其诱变性时,必须从样品中排除任何残留的组氨酸的影响,这是一个先决条件。中药如SAA是含组氨酸的生物样品,需要经过改良的Ames试验才能测定其体外致突变性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号